The Gimlet Eye sees…affective health. Using physical data for monitoring mood has a lure to it that in stressful times says ‘consumer acceptance’ — and there’s always PTSD. Both Boston-based MIT spinoff startup Neumitra and MIT Media Lab spinoff Affectiva [TA 2 July] measure the sympathetic nervous system for leading indicators of mood, such as perspiration, motion and increased temperature, processing the data through algorithms as leading indicators of possible anxiety and sending it to a platform via smartphone. Neumitra is currently being tested at Massachusetts General Hospital to gain better information on anxiety disorder triggers. Although the Technology Review article states that both are ‘experimental,’ Affectiva will be at next month’s CES Eureka Park for early-stage/startup companies.
The Eye sees…gesture control. This ReadWrite article predicts that Leap Motion will be the must-have gizmo of 2013. For $70

(to ship early 2013), you will be able to control your desktop, laptop and maybe even tablets (with USB connectivity) through hand and figure movements. Potential in healthcare could be immense: robotic surgery, rehabilitation, ability assessment, remote monitoring and socialization. Video (1:12) which only sells the ‘whiz-bang’ aspects.



A ‘Smart’ and rather modest looking stethoscope may pack a big (figurative) punch. When medication does not break up kidney stones, shock wave lithotripsy is often used, but it is difficult to tell when the fragmentation process is complete. This device monitors the pulses as they echo off the stone, and by changes in sound (‘tock’ vs. ‘tick’) can confirm that the stones are shattered (any reference to Mick’s Group is unintentional but unavoidable). In clinical trials it has reported an accuracy rate of 94.7%, far above any existing tech. The Smart Stethoscope delivers no radiation, and can also be used as an assessment tool for probable response to lithotripsy. Developed by Prof. Tim Leighton (left) at University of Southampton with Guy’s and St. Thomas’ Foundation Trust (GSTT) and UK-based tech firm Precision Acoustics Ltd. which will be developing a commercial version. 



Most Recent Comments